Table 1.
Demographic profiles for the control and recipient cohorts.
| Variable | Control cohort | Recipient cohort | p value |
|---|---|---|---|
| N = 22010 | N = 2201 | ||
| Age (year) | 51.6 ± 9.8 | 51.7 ± 9.7 | 0.9371 |
| Sex | >0.99 | ||
| Female | 5620 (25.5%) | 562 (25.5%) | |
| Male | 16390 (74.5%) | 1639 (74.5%) | |
| Comorbidities | |||
| CAD | 3189 (14.5%) | 292 (13.3%) | 0.1192 |
| DM | 2508 (11.4%) | 546 (24.8%) | <0.0001 |
| Epilepsy | 197 (0.9%) | 29 (1.3%) | 0.0494 |
| Hypertension | 6613 (30.0%) | 721 (32.8%) | 0.0083 |
| Osteoporosis | 1107 (5.0%) | 140 (6.4%) | 0.0071 |
| Stroke | 543 (2.5%) | 70 (3.2%) | 0.0422 |
| ESRD | 103 (0.5%) | 28 (1.3%) | <0.0001 |
| HBV infection | 990 (4.5%) | 1477 (67.1%) | <0.0001 |
| HCV infection | 350 (1.6%) | 630 (28.6%) | <0.0001 |
| Steroid | 11858 (53.9%) | 2061 (93.6) | |
CAD: coronary artery disease; DM: diabetes mellitus; ESRD: end-stage renal disease; HBV: hepatitis B virus; HCV: hepatitis C virus infection.